Life Sciences and Health Care

Article

What is the future for value-based healthcare?

When talking about healthcare, the focus is often on the cost of providing treatment. Over time this has been changing: most countries with developed economies are nearing the limit of what they can afford to spend on healthcare

Article

What COVID-19 has taught us about the adoption of AI in medicine and healthcare

Perspectives

Securing trust in the global COVID-19 supply chain

From development and delivery to acceptance and administration

COVID-19 vaccines and therapeutics, and the associated medical devices and consumables, present an urgent need for a protected supply chain and a system of traceability built around globally identified products.

Perspectives

How can virtual health help expand capacity in the wake of an anticipated COVID-19 surge?

When faced with a health crisis like Covid-19, social distancing can take some of the strain off healthcare providers at the front lines.  But when that’s not enough, innovations like virtual healthcare can help increase capacity, reduce the rate of infection, and treat non-urgent cases.

Perspectives

COVID-19: Shaping the future regulation of emergency medical equipment supply

The COVID-19 pandemic has disrupted everyone’s daily lives and touched every industry across the world. While many countries had influenza and other pandemic preparedness plans in place prior to COVID-19, no one was fully prepared for the speed and indiscriminate spread of the disease.

Perspectives

Intelligent biopharma

Forging the links across the value chain

The biopharmaceutical sector is facing digital disruption from multiple sources, the chief among them being artificial intelligence (AI) and cloud. Deloitte predicts that in 2019/2020, all industries will accelerate their use of cloud-based AI software and services, including biopharma companies.

Perspectives

AI in Drug Discovery

Over the past 50 years, drug discovery has focused largely on high-throughput screening for known disease-associated targets. This makes drug discovery a long, expensive and largely unsuccessful process.

Article

Intelligent drug supply chain

Creating value from AI

Protecting biopharma supply chains is a priority for companies ensuring access to lifesaving products.

Perspectives

Who will win the race to develop an effective treatment for COVID-19

Over the past 30 years, healthcare has moved from treating infectious or communicable diseases to managing a ‘tidal wave’ of complex age and behaviour related, non-communicable, diseases.

Article

The risk of fraud in fast tracking targeted COVID-19 therapeutics

Chief Compliance Officer support

Article

Evolving the product launch paradigm in pharma
 

Successfully managing a product launch to maximise returns

Article

Measuring the return from pharmaceutical innovation 2019

Ten years on